Lucid Diagnostics Inc. shares fall 5.98% intraday as MolDX convenes expert medical panel on Medicare.

miércoles, 16 de julio de 2025, 1:31 pm ET1 min de lectura
LUCD--
Lucid Diagnostics Inc. declined 5.98% in intraday trading, with the company announcing that MolDX-participating Medicare Administrative Contractors will convene a MolDX Contractor Advisory Committee (CAC) Meeting of medical experts on September 4, 2025. This meeting is a critical step in the reconsideration of Local Coverage Determination (LCD) L39256, 'MolDX: Molecular Testing'.

Lucid Diagnostics Inc. shares fall 5.98% intraday as MolDX convenes expert medical panel on Medicare.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios